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It is well acknowledged that the poor prognosis of gas-
trointestinal cancer is largely due to metastasis, which is the
biological hallmark of malignant tumors. Metastasis is con-
sidered to be a multistep process in which malignant tumor
cells spread inconsecutively from original site to distant
organs. As for cancers of gastrointestinal tract, the common
target site for metastasis is liver, lymph nodes, peritoneal,
and, subsequently, lung and other sites of the body, which
in single or as a whole, is the major cause of gastrointestinal
cancer-related deaths.
Therefore, the early diagnosis and effective treatment
of gastrointestinal cancer metastasis is of vital importance,
which may lead to substantial elongation of life expectancy
of gastrointestinal cancer patients. In order to make further
progressions in early diagnosis and intervention, the follow-
ing three directions should be put due emphases on in future
research.
Firstly, the cellular and molecular mechanisms of gas-
trointestinal cancer metastasis should be clarified, such as
the mechanisms of local angiogenesis, the heterogeneity of
cancer cells, the cross-talk and cascade of signaling trans-
duction systems, the decreased expression of cell adhesion
molecules such as E-cadherin, and so on. To elucidate these
mechanisms and to block relevant molecular pathways pro-
vides the most promising perspectives in the fight against
gastrointestinal caner metastasis. And additionally, there are
several interesting and enlightening hot points: the rela-
tionship between stromal microenvironment and metastatic
destination; the role of cancer stem cells in metastasis;
and how malignant cells get metastasis ability, inherent or
acquired?
The second direction is to find out specific and sensible
biomarkers of gastrointestinal cancer metastasis and to
predict the potential metastasis, to facilitate early diagnosis,
which is up to now mainly dependent on insensitive and
costly radiographic examinations. And the third one is the
optimization of comprehensive treatment including surgical
intervention.
In this special issue, eight articles on gastrointestinal
cancer metastasis are presented. One article discussed the
advantages and disadvantages of repeated liver resection in
patients with recurrent colorectal liver metastasis. One article
reported that N-desulfated heparin is capable of suppressing
the metastasis of gastric cancer through inhibiting tumor
bFGF expression and tumor angiogenesis with no obvious
anticoagulant activity. Yet another article is on the relevance
between dietary salt intake and the risk of gastric cancer.
The other five articles highlighted four kinds of potential
biomarkers for gastrointestinal cancer screening and early
diagnosis of metastasis, namely urine-free amino acid, ki-
67 antigen, mir-21 and epidermal growth factor receptor
(EGFR). J. Fan and his colleagues, through analyzing amino
acids in urine samples of gastric cancer patients and healthy
volunteers, figured out that urine-free amino acid profiling
is of potential value for screening or diagnosing gastric
cancer. D. Navarini and his colleagues, from Brazil, reviewed
thirty-seven patients who underwent esophagectomy with-
out presurgical chemotherapy or radiotherapy from 2000 to
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2010, analyzed the level of EGFR expression and life span,
and concluded that EGFR expression is related to higher
TNM staging and shorter survival.
Despite the obvious advancements made in the research
of gastrointestinal cancer metastasis these years, the out-
comes are far from final satisfaction, and thus it is still a field
that deserves and calls for intensive and thorough research in
the future.
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